Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Arthritis, Juvenile

• A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
• Coenzyme Q10 in Juvenile Idiopathic Arthritis Patients
• A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
• A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
• Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthriti
• Biologic Therapy in Pediatric JIA Uveitis
• Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)
• A Study of Ustekinumab in Pediatric Participants
• A Study of Ustekinumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
• Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection
• Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
• Hip Denervation in Juvenile Idiopathic Arthritis With Hip Arthritis
• A Study to Evaluate AEVI-007 in Participants With Adult Onset Still's Disease
• Genicular Nerve Block in Juvenile Idiopathic Arthritis
• Strategies Towards Personalised Treatment in Juvenile Idiopathic Arthritis (JIA).
• Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis
• A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
• Clinical Study of Genakumab for Injection in Chinese Healthy Volunteers
• The Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis
• A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With sJIA
• Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS
• Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)
• Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis
• Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
• A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
• A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
• An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
• STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS
• A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis
• A Study to Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHL
• A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)
• A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD)
• Intranasal Dexmedetomidine Sedation During Intra-articular Joint Injections in Pediatric Population
• Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)
• A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA
• A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)
• Treatment Tapering in JIA With Inactive Disease
• Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)
• An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
• Efficacy Study Of Tofacitinib In Pediatric JIA Population
• Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders
• A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies
• ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab
• A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy
• Canakinumab for Treatment of Adult-onset Still's Disease
• Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis
• Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis
• Efficacy Study of Leflunomide to Treat Juvenile Idiopathic Arthritis
• A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis
• A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA)
• Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan
• Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
• A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)
• An Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopathic Arthritis Who Completed The WA19977 Study
• Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
• An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
• A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis From France Who Completed WA19977 Core Study
• A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis Who Completed WA19977 Core Study
• Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis
• An Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis
• Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
• Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arthritis
• Pediatric Arthritis Study of Certolizumab Pegol
• A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA)
• Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)
• Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis
• A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)
• Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
• Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers
• Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis
• Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic Arthritis
• A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)
• Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance]
• Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study
• Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
• Efficacy and Safety of Tocilizumab in Adult's Still Disease
• A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis
• Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
• An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With
• Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
• Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
• Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab
• Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease
• A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects
• Juvenile Idiopathic Arthritis (JIA) Registry
• Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use
• Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis
• A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA
• A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)
• Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis
• Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA
• Open Label, Multicentre Trial to Assess Safety and Efficacy of ITF2357 in Active Systemic Juvenile Idiopathic Arthritis
• Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease
• Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children
• Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
• Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
• Efficacy and Safety of Growth Hormone Treatment in Juvenile Idiopathic Arthritis
• PRINTO (the Paediatric Rheumatology International Trials Organisation)
• Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis
• Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
• Effects of Growth Hormone in Chronically Ill Children
• A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)
• Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain
• Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)
• Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)
• Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)
• Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)
• Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis
• BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
• Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
• Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
• Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)
• Juvenile Rheumatoid Arthritis
• A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis
• Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)
• Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
• The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis
• Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
• Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis
• TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis
• The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis
• Calcium Supplements for Bone Health in Juvenile Rheumatoid Arthritis